Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05260164
Other study ID # BTL-899_CTBG200
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 11, 2022
Est. completion date January 30, 2023

Study information

Verified date April 2023
Source BTL Industries Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate the clinical safety and the performance of the BTL-899 device (with its 899-AP-C-4 and 899-AP-C-5 applicators) during treatment of the flanks (also known as "love handles"). The study has a single-arm, open-label, interventional design. The subjects will be enrolled and assigned into one study arm and will be required to complete four (4) treatment visits. Both flanks will be treated simultaneously for 30 minutes per session. The flanks' fat thickness reduction will be documented by ultrasound. At the baseline visits health status will be assessed and, if needed, additional tests will be performed. Inclusion and exclusion criteria will be verified and informed consent will be signed. The treatment administration phase consists of four (4) treatment visits, delivered 5 - 10 days apart. At every treatment visit after the first, prior to the procedure, the participants will be assessed for adverse effects resulting from the previous treatment(s) with the BTL-899 device. Safety measures will include documentation of adverse events (AE) during and after the procedures. Follow-ups visits at 1 month and 3 months after the final treatment will be held.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date January 30, 2023
Est. primary completion date November 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Body Mass Index (BMI) of 20 to 35 kg/m2. - Visible excess of adipose tissue confirmed with pinch test at the flanks ("love handles") area. - Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring and/or weight loss during study participation. - Successful initial determination of the flanks' fat thickness by means of ultrasound. - No procedure for fat reduction at the treated area in the last six months. - Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting a significant change of weight in either direction during study participation. - Age between 18 and 70 years. Exclusion Criteria: - Electronic implants (such as intrauterine device, cardiac pacemakers, defibrillators, and neurostimulators) - Metal implants - Drug pumps - Malignant tumor - Pulmonary insufficiency - Injured or otherwise impaired muscles in the treatment area - Cardiovascular diseases - Disturbance of temperature or pain perception - Hemorrhagic conditions - Septic conditions and empyema - Acute inflammations - Systemic or local infection such as osteomyelitis and tuberculosis - Contagious skin disease - Elevated body temperature - Pregnancy, postpartum period, nursing - Graves' disease - Scars, open lesions, and wounds at the treatment area - Abdominal hernia - Gynecological disease incl. inflammation in the pelvis - Hip and rib cage trauma or recent surgery of those - Previous liposuction in the treatment area in the last six months - Unstable weight within the last 6 months (change in weight ± 3%) - Previous body contouring or cellulite treatments in the flanks area in the last six months - Any other disease or condition at the investigator's discretion

Study Design


Related Conditions & MeSH terms


Intervention

Device:
HIFEM+RF
Combination of High-Intensity Focused Electromagnetic Field (HIFEM) and a high radio frequency (RF) field.

Locations

Country Name City State
Bulgaria Outpatient Practice for Specialized Medical Care - Individual practice for specialized medical dermatology care Mariya Genova MD Plovdiv

Sponsors (1)

Lead Sponsor Collaborator
BTL Industries Ltd.

Country where clinical trial is conducted

Bulgaria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of fat thickness in the flanks area evaluated by ultrasound To gather clinical evidence that the BTL-899 device is able to induce non-invasive lipolysis when used on human flanks 5 months
Secondary Evaluation of the Therapy's Safety Measured Via Therapy Comfort Questionnaire Assessment the safety of the BTL-899 device when used for non-invasive lipolysis of the flanks via questionnaires filled in by the participants following each therapy session. On Numerical Analog Scale (0-10), where 0 represents 'no pain' and 10 represents 'worst possible pain' select the level of pain experienced during the treatment. The outcome will further be measured through the occurrence of adverse events or lack thereof. 5 months
Secondary Evaluation of the participants' satisfaction with the therapy evaluated via standard questionnaires Majority of the treated subjects to report satisfaction (level satisfied and higher) with the therapy. 5 months
See also
  Status Clinical Trial Phase
Completed NCT04599257 - Fat Reduction and Muscle Toning of Thighs N/A
Completed NCT05580263 - Different Order of Concurrent Training on Improving Visceral Adipose Tissue and Insulin Resistance. N/A
Completed NCT04643275 - Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms N/A
Completed NCT05139745 - Histological Evaluation of BTL-899 Device´s Effect on Fat Tissue N/A
Completed NCT05975489 - Genetics in the Effect of Caffeine on Fat Oxidation N/A
Completed NCT04621019 - BTL-785F Device for Non-invasive Lipolysis and Circumference Reduction of the Abdomen N/A
Completed NCT04696614 - Testing the Effect of Exercise Intervention Using a SMART Design. N/A
Completed NCT04455009 - Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism N/A
Recruiting NCT05261373 - Efficacy of a Nutritional Education Strategy and Physical Exercise on the Gut Microbiota in Type 2 Diabetics N/A
Recruiting NCT04043182 - EFFECTIVENESS OF ULTRASOUND FOR LOCAL FAT TREATMENT N/A
Completed NCT04587804 - Abdomen - Fat Reduction and Muscle Toning N/A
Completed NCT05540080 - Non-invasive Lipolysis and Improvement of Muscle Tone in Lateral Abdomen N/A
Completed NCT04587986 - rPMS and Radiofrequency for Abdominal Toning and Reduction of Subcutaneous Fat N/A
Active, not recruiting NCT06274177 - Evaluation of the BTL-785F Device for Submental Fat Reduction and Neck Rejuvenation N/A
Completed NCT06282172 - Histological Evaluation of BTL-785F Device's Effect on Submental Subcutaneous Adipose Tissue N/A
Not yet recruiting NCT03357601 - High Intensity Interval Training vs Moderate Continuous Endurance Exercise Training on Program Adherence N/A
Completed NCT05215275 - Comparison of Different Exercise Trainings on Heart Rate Variability N/A
Completed NCT03811093 - Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss N/A
Active, not recruiting NCT06333496 - Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans N/A
Not yet recruiting NCT06219850 - Physical Exercise, Diet, and Health in People With Type 2 Diabetes: Longitudinal Design of the EDUGUTION Study